Cargando…
PAQR8 promotes breast cancer recurrence and confers resistance to multiple therapies
BACKGROUND: Breast cancer mortality is principally due to recurrent disease that becomes resistant to therapy. We recently identified copy number (CN) gain of the putative membrane progesterone receptor PAQR8 as one of four focal CN alterations that preferentially occurred in recurrent metastatic tu...
Autores principales: | Chen, Saisai, Paul, Matt R., Sterner, Christopher J., Belka, George K., Wang, Dezhen, Xu, Peining, Sreekumar, Amulya, Pan, Tien-chi, Pant, Dhruv K., Makhlin, Igor, DeMichele, Angela, Mesaros, Clementina, Chodosh, Lewis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811758/ https://www.ncbi.nlm.nih.gov/pubmed/36597146 http://dx.doi.org/10.1186/s13058-022-01559-3 |
Ejemplares similares
-
Analytical considerations for reducing the matrix effect for the sphingolipidome quantification in whole blood
por: Wang, Dezhen, et al.
Publicado: (2021) -
Impact of obesity on breast cancer recurrence and minimal residual disease
por: Ecker, Brett L., et al.
Publicado: (2019) -
Trastuzumab deruxtecan: An antibody-drug conjugate embracing its destiny in breast cancer
por: Makhlin, Igor, et al.
Publicado: (2022) -
Cellular dormancy in minimal residual disease following targeted therapy
por: Ruth, Jason R., et al.
Publicado: (2021) -
Leveraging a gain-of-function allele of Caenorhabditis elegans paqr-1 to elucidate membrane homeostasis by PAQR proteins
por: Busayavalasa, Kiran, et al.
Publicado: (2020)